Effects of Obstructive Sleep Apnea and Obesity on Morphine Pharmacokinetics in Children

Overview

Journal Anesth Analg

Specialty Anesthesiology

Date 2019 Nov 6

PMID 31688081

Citations 5

Authors

Nicholas M Dalesio

Carlton K K Lee

Craig W Hendrix

Nikole Kerns

Aaron Hsu

William Clarke

Joseph M Collaco

Sharon McGrath-Morrow

Myron Yaster

Robert H Brown

Alan R Schwartz

Affiliations

Soon will be listed here.

Abstract

Background: Obesity increases susceptibility to chronic pain, increases metabolism, and is associated with obstructive sleep apnea syndrome (OSAS), all which can complicate perioperative pain management of patients. In addition, obesity and OSAS can cause elevation of the adipose-derived hormone leptin, which increases metabolism. We hypothesized that obesity along with sleep apnea and leptin independently enhance morphine pharmacokinetics.

Methods: Children 5-12 years of age who were presenting for surgery were administered a morphine dose of 0.05 mg/kg. Blood was collected at baseline and at subsequent preset times for pharmacokinetic analysis of morphine and its metabolites. Three groups were studied: a nonobese group with severe OSAS, an obese group with severe OSAS, and a control group.

Results: Thirty-four patients consisting of controls (n = 16), nonobese/OSAS (n = 8), and obese/OSAS (n = 10) underwent analysis. The obese/OSAS group had a higher dose-adjusted mean maximum morphine concentration (CMAX) over 540 minutes compared to the controls (P < .001) and those with only OSAS (P = .014). The obese/OSAS group also had lower volume of distribution (Vd) when compared to OSAS-only patients (P = .007). In addition, those in the obese/OSAS group had a higher morphine 3-glucuronide (M3G) maximum concentration (P = .012) and a higher ratio of M3G to morphine than did the control group (P = .011). Time to maximum morphine 6-glucuronide (M6G) concentration was significantly lower in both nonobese/OSAS and obese/OSAS groups than in the control group (P < .005). C-reactive protein (CRP), interleukin (IL)-10, and leptin were all higher in the obese/OSAS group than in controls (P = .004, 0.026, and <0.001, respectively), and compared to OSAS-only patients, CRP (P = .013) and leptin (P = .002) levels were higher in the obese/OSAS group.

Conclusions: The combination of obesity and OSAS was associated with an increase in morphine metabolism compared with that in normal-weight controls. Our previous study in mice demonstrated that obesity from leptin deficiency decreased morphine metabolism, but that metabolism normalized after leptin replacement. Leptin may be a cause of the increased morphine metabolism observed in obese patients.

Citing Articles

Untargeted Metabolomics and Body Mass in Adolescents: A Cross-Sectional and Longitudinal Analysis.

Singh A, Kinnebrew G, Hsu P, Weng D, Song M, Reisinger S Metabolites. 2023; 13(8).

PMID: 37623843 PMC: 10456720. DOI: 10.3390/metabo13080899.

Associations between cardiometabolic phenotypes and levels of TNF-α, CRP, and interleukins in obstructive sleep apnea.

Fei Q, Tan Y, Yi M, Zhao W, Zhang Y Sleep Breath. 2022; 27(3):1033-1042.

PMID: 35982289 DOI: 10.1007/s11325-022-02697-w.

Obesity in childhood.

Masaracchia M, Lee M, Dalesio N BJA Educ. 2022; 22(5):168-175.

PMID: 35496648 PMC: 9039480. DOI: 10.1016/j.bjae.2021.12.003.

The Association Between Serum/Plasma Leptin Levels and Obstructive Sleep Apnea Syndrome: A Meta-Analysis and Meta-Regression.

Li X, He J Front Endocrinol (Lausanne). 2021; 12:696418.

PMID: 34671315 PMC: 8522441. DOI: 10.3389/fendo.2021.696418.

Paediatrics: how to manage obstructive sleep apnoea syndrome.

Leung T, Cheng J, Chan A Drugs Context. 2021; 10.

PMID: 33828609 PMC: 8007210. DOI: 10.7573/dic.2020-12-5.

References

Mutlib A, Goosen T, Bauman J, Williams J, Kulkarni S, Kostrubsky S . Kinetics of acetaminophen glucuronidation by UDP-glucuronosyltransferases 1A1, 1A6, 1A9 and 2B15. Potential implications in acetaminophen-induced hepatotoxicity. Chem Res Toxicol. 2006; 19(5):701-9. DOI: 10.1021/tx050317i. View

Sans Capdevila O, Kheirandish-Gozal L, Dayyat E, Gozal D . Pediatric obstructive sleep apnea: complications, management, and long-term outcomes. Proc Am Thorac Soc. 2008; 5(2):274-82. PMC: 2645258. DOI: 10.1513/pats.200708-138MG. View

Tauman R, Serpero L, Sans Capdevila O, OBrien L, Goldbart A, Kheirandish-Gozal L . Adipokines in children with sleep disordered breathing. Sleep. 2007; 30(4):443-9. DOI: 10.1093/sleep/30.4.443. View

Sanders J, King M, Mitchell R, Kelly J . Perioperative complications of adenotonsillectomy in children with obstructive sleep apnea syndrome. Anesth Analg. 2006; 103(5):1115-21. DOI: 10.1213/01.ane.0000244318.77377.67. View

Brill M, Diepstraten J, van Rongen A, van Kralingen S, van den Anker J, Knibbe C . Impact of obesity on drug metabolism and elimination in adults and children. Clin Pharmacokinet. 2012; 51(5):277-304. DOI: 10.2165/11599410-000000000-00000. View

Frink Jr E, Morgan S, Coetzee A, Conzen P, Brown Jr B . The effects of sevoflurane, halothane, enflurane, and isoflurane on hepatic blood flow and oxygenation in chronically instrumented greyhound dogs. Anesthesiology. 1992; 76(1):85-90. DOI: 10.1097/00000542-199201000-00013. View

Jimenez N, Posner K, Cheney F, Caplan R, Lee L, Domino K . An update on pediatric anesthesia liability: a closed claims analysis. Anesth Analg. 2006; 104(1):147-53. DOI: 10.1213/01.ane.0000246813.04771.03. View

Meineke I, Freudenthaler S, Hofmann U, Schaeffeler E, Mikus G, Schwab M . Pharmacokinetic modelling of morphine, morphine-3-glucuronide and morphine-6-glucuronide in plasma and cerebrospinal fluid of neurosurgical patients after short-term infusion of morphine. Br J Clin Pharmacol. 2002; 54(6):592-603. DOI: 10.1046/j.1365-2125.2002.t01-1-01689.x. View

Gabrielsson J, Weiner D . Non-compartmental analysis. Methods Mol Biol. 2012; 929:377-89. DOI: 10.1007/978-1-62703-050-2_16. View

10.

Rabbitts J, Groenewald C, Dietz N, Morales C, Rasanen J . Perioperative opioid requirements are decreased in hypoxic children living at altitude. Paediatr Anaesth. 2011; 20(12):1078-83. DOI: 10.1111/j.1460-9592.2010.03453.x. View

11.

Gleich S, Olson M, Sprung J, Weingarten T, Schroeder D, Warner D . Perioperative outcomes of severely obese children undergoing tonsillectomy. Paediatr Anaesth. 2012; 22(12):1171-8. PMC: 3470734. DOI: 10.1111/j.1460-9592.2012.03905.x. View

12.

Kang M, Mischel R, Bhave S, Komla E, Cho A, Huang C . The effect of gut microbiome on tolerance to morphine mediated antinociception in mice. Sci Rep. 2017; 7:42658. PMC: 5314392. DOI: 10.1038/srep42658. View

13.

Nasrallah M, Ziyadeh F . Overview of the physiology and pathophysiology of leptin with special emphasis on its role in the kidney. Semin Nephrol. 2013; 33(1):54-65. DOI: 10.1016/j.semnephrol.2012.12.005. View

14.

Stanski D, Greenblatt D, Lowenstein E . Kinetics of intravenous and intramuscular morphine. Clin Pharmacol Ther. 1978; 24(1):52-9. DOI: 10.1002/cpt197824152. View

15.

Statham M, Elluru R, Buncher R, Kalra M . Adenotonsillectomy for obstructive sleep apnea syndrome in young children: prevalence of pulmonary complications. Arch Otolaryngol Head Neck Surg. 2006; 132(5):476-80. DOI: 10.1001/archotol.132.5.476. View

16.

Lloret-Linares C, Hirt D, Bardin C, Bouillot J, Oppert J, Poitou C . Effect of a Roux-en-Y gastric bypass on the pharmacokinetics of oral morphine using a population approach. Clin Pharmacokinet. 2014; 53(10):919-30. DOI: 10.1007/s40262-014-0163-0. View

17.

Ip M, Lam K, Ho C, Tsang K, Lam W . Serum leptin and vascular risk factors in obstructive sleep apnea. Chest. 2000; 118(3):580-6. DOI: 10.1378/chest.118.3.580. View

18.

Miyamoto L, Ebihara K, Kusakabe T, Aotani D, Yamamoto-Kataoka S, Sakai T . Leptin activates hepatic 5'-AMP-activated protein kinase through sympathetic nervous system and α1-adrenergic receptor: a potential mechanism for improvement of fatty liver in lipodystrophy by leptin. J Biol Chem. 2012; 287(48):40441-7. PMC: 3504759. DOI: 10.1074/jbc.M112.384545. View

19.

de Hoogd S, Valitalo P, Dahan A, van Kralingen S, Coughtrie M, van Dongen E . Influence of Morbid Obesity on the Pharmacokinetics of Morphine, Morphine-3-Glucuronide, and Morphine-6-Glucuronide. Clin Pharmacokinet. 2017; 56(12):1577-1587. PMC: 5694499. DOI: 10.1007/s40262-017-0544-2. View

20.

Redline S, Tishler P, Schluchter M, Aylor J, Clark K, Graham G . Risk factors for sleep-disordered breathing in children. Associations with obesity, race, and respiratory problems. Am J Respir Crit Care Med. 1999; 159(5 Pt 1):1527-32. DOI: 10.1164/ajrccm.159.5.9809079. View